University of Tasmania
13
3
5
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
7.7%
1 terminated/withdrawn out of 13 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
50%
2 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
A Model for Genetic Susceptibility: Melanoma
Role: collaborator
PLatform for Adaptive Trials In Perinatal UnitS - [Core Protocol]
Role: collaborator
Ultra Crave: An Investigation of Ultra-Processed Food
Role: collaborator
A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease
Role: collaborator
Physical Function, Health and Employment for People With Multiple Sclerosis
Role: collaborator
Cigarette Pack Inserts for Smoking Cessation
Role: collaborator
TapTalkTest Project:Development of a Non-invasive Screening Test to Detect Risk of Alzheimer's Disease Pathology
Role: lead
Automated Versus Manual Control Of Oxygen For Preterm Infants On Continuous Positive Airway Pressure In Nigeria
Role: collaborator
TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease
Role: lead
Comparison of Oxygen Controllers in Preterm InfanTs
Role: collaborator
Exosome Proteomics to Detect EPO
Role: collaborator
The Effect of Urox™ in the Treatment of Overactive Bladder and Urinary Incontinence
Role: collaborator
The Impact of Problem-Based Learning (PBL) and Lecturing
Role: lead
All 13 trials loaded